NOVAVAX Trademark

Trademark Overview

On Thursday, September 2, 2021, a trademark application was filed for NOVAVAX with the United States Patent and Trademark Office. The USPTO has given the NOVAVAX trademark a serial number of 97008364. The federal status of this trademark filing is REGISTERED as of Tuesday, September 3, 2024. This trademark is owned by Novavax, Inc.. The NOVAVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for medical purposes
novavax

General Information

Serial Number97008364
Word MarkNOVAVAX
Filing DateThursday, September 2, 2021
Status700 - REGISTERED
Status DateTuesday, September 3, 2024
Registration Number7495865
Registration DateTuesday, September 3, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Description of MarkThe mark consists of the word "NOVAVAX" to the left of a circle made up of smaller different shaped circles.
Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases; vaccines; adjuvants for medical purposes
Pseudo MarkNOVA VAX; NOVA V AX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 15, 2021
Primary Code005
First Use Anywhere DateSunday, October 15, 2023
First Use In Commerce DateSunday, October 15, 2023

Trademark Owner History

Party NameNovavax, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878
Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, September 6, 2021NEW APPLICATION ENTERED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 16, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 31, 2022ASSIGNED TO EXAMINER
Thursday, March 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 31, 2022NON-FINAL ACTION WRITTEN
Thursday, March 31, 2022NON-FINAL ACTION E-MAILED
Friday, July 29, 2022EXAMINER'S AMENDMENT ENTERED
Friday, July 29, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, July 29, 2022EXAMINERS AMENDMENT E-MAILED
Friday, July 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, August 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 13, 2023SOU EXTENSION 1 FILED
Wednesday, March 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU EXTENSION 2 FILED
Tuesday, October 10, 2023SOU EXTENSION 2 GRANTED
Monday, March 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 8, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2024USE AMENDMENT FILED
Wednesday, June 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, July 27, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, July 27, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 3, 2024REGISTERED-PRINCIPAL REGISTER
Monday, May 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 12, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 12, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, May 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

novavax adjuvants medical purposes vaccines diseases preparations treatment infectious pharmaceutical